• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset

tetano

Editor, Senior Moderator
Cell Rep Med


. 2021 May 5;100290.
doi: 10.1016/j.xcrm.2021.100290. Online ahead of print.
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset


Sai Priya Anand[SUP] 1 2 [/SUP], J?r?mie Pr?vost[SUP] 2 3 [/SUP], Manon Nayrac[SUP] 2 3 [/SUP], Guillaume Beaudoin-Bussi?res[SUP] 2 3 [/SUP], Mehdi Benlarbi[SUP] 2 [/SUP], Romain Gasser[SUP] 2 3 [/SUP], Nathalie Brassard[SUP] 2 [/SUP], Annemarie Laumaea[SUP] 2 3 [/SUP], Shang Yu Gong[SUP] 1 2 [/SUP], Catherine Bourassa[SUP] 2 [/SUP], Elsa Brunet-Ratnasingham[SUP] 2 3 [/SUP], Halima Medjahed[SUP] 2 [/SUP], Gabrielle Gendron-Lepage[SUP] 2 [/SUP], Guillaume Goyette[SUP] 2 [/SUP], Laurie Gokool[SUP] 2 [/SUP], Chantal Morrisseau[SUP] 2 [/SUP], Philippe B?gin[SUP] 2 4 [/SUP], Val?rie Martel-Laferri?re[SUP] 2 3 [/SUP], C?cile Tremblay[SUP] 2 3 [/SUP], Jonathan Richard[SUP] 2 3 [/SUP], Ren?e Bazin[SUP] 5 [/SUP], Ralf Duerr[SUP] 6 [/SUP], Daniel E Kaufmann[SUP] 2 7 [/SUP], Andr?s Finzi[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

With the recent approval of highly effective COVID-19 vaccines, functional and lasting immunity to SARS-CoV-2 is currently under investigation as antibody levels in plasma were shown to decline during convalescence. Since the absence of antibodies does not equate to absence of immune memory, we evaluate the presence of SARS-CoV-2-specific memory B cells in convalescent individuals. Here we report a longitudinal assessment of humoral immune responses on 32 donors up to 8 months post-symptom onset. Our observations indicate that anti-Spike and anti-RBD IgM in plasma decay rapidly, whereas the reduction of IgG is less prominent. Neutralizing activity also declines rapidly when compared to Fc-effector functions. Concomitantly, the frequencies of RBD-specific IgM+ B cells wane significantly when compared to RBD-specific IgG+ B cells which remain stable. Our results add to the current understanding of immune memory following SARS-CoV-2 infection, which is critical for the prevention of secondary infections and vaccine efficacy.

Keywords: ADCC; Antibodies; COVID-19; Convalescent plasma; Coronavirus; Humoral responses; Memory B cells; Neutralization; RBD; SARS-CoV-2; Serology; Spike glycoproteins.
 
Back
Top Bottom